drugset / Trial / NCT01762943

Summary

Understanding the neural and biological mechanisms by which reproductive hormones influence mood is critically important for public health given that postpartum depression (PPD) is the leading cause of morbidity and mortality associated with childbirth and has negative effects on infants. Using a hormone-withdrawal challenge to precipitate mood symptoms will improve our ability to identify the biological mechanisms underlying both the triggering of and susceptibility to depressive disorders in women; and will permit the prediction of those at risk for PPD and other reproductive-related mood disorders.

Timeline

Start
2013-08
Primary completion
2016-10-13
Completion
2016-10-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 10 mg
Subject Leuprolide Other / unclassified 3.75 mg Intramuscular
Subject Progesterone Other / unclassified 800 mg

Indications